Novel compounds that synergize with aminoglycoside G418 or eRF3 degraders for translational readthrough of nonsense mutant TP53 and PTEN

Angelos Heldina Department of Oncology-Pathology, BioClinicum, Karolinska Institutet, Stockholm, SwedenView further author information

Matko Cancera Department of Oncology-Pathology, BioClinicum, Karolinska Institutet, Stockholm, SwedenView further author information

Mireia Palomar-Silesa Department of Oncology-Pathology, BioClinicum, Karolinska Institutet, Stockholm, SwedenView further author information

Susanne Öhlina Department of Oncology-Pathology, BioClinicum, Karolinska Institutet, Stockholm, SwedenView further author information

Meiqiongzi Zhanga Department of Oncology-Pathology, BioClinicum, Karolinska Institutet, Stockholm, SwedenView further author information

Alexander Sun-Zhanga Department of Oncology-Pathology, BioClinicum, Karolinska Institutet, Stockholm, SwedenView further author information

Anna Mariania Department of Oncology-Pathology, BioClinicum, Karolinska Institutet, Stockholm, SwedenView further author information

Jianping Liub Department of Medicine, Karolinska Institutet, Huddinge, SwedenView further author information

Vladimir J.N. Bykova Department of Oncology-Pathology, BioClinicum, Karolinska Institutet, Stockholm, SwedenView further author information

Klas G. Wimana Department of Oncology-Pathology, BioClinicum, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]

Your download is now in progress and you may close this window